DE60122721D1 - Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers - Google Patents

Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers

Info

Publication number
DE60122721D1
DE60122721D1 DE60122721T DE60122721T DE60122721D1 DE 60122721 D1 DE60122721 D1 DE 60122721D1 DE 60122721 T DE60122721 T DE 60122721T DE 60122721 T DE60122721 T DE 60122721T DE 60122721 D1 DE60122721 D1 DE 60122721D1
Authority
DE
Germany
Prior art keywords
tzon7
protein
polynucleotides
antibody
cell protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60122721T
Other languages
English (en)
Other versions
DE60122721T2 (de
Inventor
Nalan Utku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Utku Nalan Dr 10719 Berlin De
Brigham and Womens Hospital Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60122721(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60122721D1 publication Critical patent/DE60122721D1/de
Publication of DE60122721T2 publication Critical patent/DE60122721T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60122721T 2000-07-03 2001-07-03 Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers Expired - Lifetime DE60122721T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00114234 2000-07-03
EP00114234 2000-07-03
PCT/EP2001/007610 WO2002002619A1 (en) 2000-07-03 2001-07-03 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof

Publications (2)

Publication Number Publication Date
DE60122721D1 true DE60122721D1 (de) 2006-10-12
DE60122721T2 DE60122721T2 (de) 2007-10-11

Family

ID=8169143

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122721T Expired - Lifetime DE60122721T2 (de) 2000-07-03 2001-07-03 Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers

Country Status (6)

Country Link
US (1) US20030219424A1 (de)
EP (1) EP1297011B1 (de)
AT (1) ATE338063T1 (de)
AU (1) AU2001281943A1 (de)
DE (1) DE60122721T2 (de)
WO (1) WO2002002619A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118061B (fi) * 2001-09-24 2007-06-15 Beanor Oy Menetelmä ja bioanturi analyysiä varten
FI115166B (fi) * 2001-12-31 2005-03-15 Biofons Oy Diagnostisia menetelmiä

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4081000A (en) * 1999-04-09 2000-11-14 Human Genome Sciences, Inc. Uncoupling proteins
EP1190051A2 (de) * 1999-06-17 2002-03-27 Incyte Genomics, Inc. Menschliche transportproteine

Also Published As

Publication number Publication date
DE60122721T2 (de) 2007-10-11
EP1297011B1 (de) 2006-08-30
ATE338063T1 (de) 2006-09-15
EP1297011A1 (de) 2003-04-02
AU2001281943A1 (en) 2002-01-14
WO2002002619A1 (en) 2002-01-10
US20030219424A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
HUP0500345A2 (hu) Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
DE60332645D1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
ATE443161T1 (de) Mittel und verfahren für den nachweis von methylierter dna
NO995002D0 (no) Modifiserte TNF-<alfa>-molekyler, DNA som koder for slike modifiserte TNF-<alfa>-molekyler og vaksiner omfattende slike TNF-<alfa>-molekyler og DNA
AR038568A1 (es) Anticuerpos anti-a beta y su uso
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
WO2001068708A3 (en) Human and humanized fap-alpha-specific antibodies
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
DE69032598T2 (de) Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
HUP0302566A2 (hu) Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására
DE60122721D1 (de) Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
WO2004011496A3 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
ATE399019T1 (de) Verwendungen von tgap7 zur modulation der aktivierung von leukozyten
DK0811067T3 (da) Equin arteritisviruspeptider, antistoffer og deres anvendelse i en diagnostisk test
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
ATE417825T1 (de) Neue gene tzap7/a, tzap7/b and tzap7 welche in die t zellen aktivierung involviert sind, und deren verwendungen
UA84840C2 (ru) Нуклеотидная последовательность, которая кодирует tolc, плазмида, протеин или пептид, бактерия, фармацевтический препарат, диагностический набор и связующее средство для препаратов
BR0213029A (pt) Receptor acoplado por proteìna g, gave10
AR036104A1 (es) Un receptor acoplado a la proteina g, gave3

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE BRIGHAM AND WOMEN'S HOSPITAL INC., BOSTON,, US

Owner name: UTKU, NALAN, DR., 10719 BERLIN, DE

8381 Inventor (new situation)

Inventor name: UTKU, NALAN, 10719 BERLIN, DE

Inventor name: MILFORD, EDGAR L., DOVER, MASS., US

8328 Change in the person/name/address of the agent

Representative=s name: KOENIG SZYNKA TILMANN VON RENESSE, 40549 DUESSELDO